Zoplar, a platform designed to streamline the medical equipment procurement process for small and medium-sized hospitals, has raised $3.4 million in a Series A funding round led by Blume Ventures. Additional participation came from Beenext, Saison Capital, Atrium Angels, Finfirst, and LogX.
With this round, Zoplar’s total funding has reached $5.1 million, including contributions from Titan Capital, Stride Ventures, and Panthera Peak in earlier rounds.
The company plans to utilize the funds to enhance its operational infrastructure, focusing on backward integration in the supply chain and developing a robust service engineering team, according to its press release.
Aiming to Solve MSME Hospitals’ Procurement Challenges
Founded in 2022 by Amit Sah and Umesh Sharma, Zoplar is a full-stack medical equipment platform addressing the unique challenges faced by small and medium-sized hospitals. These include:
- Identifying cost-efficient products.
- Managing relationships with multiple vendors.
- Ensuring high-quality after-sales support.
- Accessing financing solutions.
Since its inception, Zoplar has made notable strides, partnering with around 300 hospitals, including leading nephrology chains such as DCDC.
Building Momentum in the Sector
Headquartered in Gurugram, Zoplar has demonstrated strong market traction, with a 40% repeat customer rate. This highlights the growing demand for streamlined and reliable medical equipment procurement solutions in the healthcare sector.
By focusing on operational excellence and customer-centric innovations, Zoplar aims to cement its position as a go-to platform for medical equipment in India’s MSME hospital ecosystem.
